ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 145 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $644,575 | -33.7% | 25,228 | -25.6% | 0.05% | -44.4% |
Q2 2023 | $972,367 | +446.1% | 33,904 | +356.4% | 0.09% | +109.3% |
Q1 2023 | $178,049 | +1593.3% | 7,428 | +1098.1% | 0.04% | +1333.3% |
Q4 2022 | $10,515 | – | 620 | +61900.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 1 | -99.7% | 0.00% | -100.0% |
Q3 2021 | $14,000 | – | 299 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |